UAE's Contraceptive Devices Market is expected to witness growth from $65 Mn in 2022 to $129 Mn in 2030 with a CAGR of 6.00% for the forecasted year 2022-30. In the UAE, particularly among young people, there is a high frequency of STDs. Because of this, there is an increased need for barrier methods of contraception like condoms, which is boosting the market for contraceptive manufacturers. The market is segmented by type and by gender. Some key players in this market include Julphar Life, Neopharma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Turkey's ENT Devices Market is projected to grow from $190 Mn in 2022 to $300 Mn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Turkey ENT devices market include Fako Elektronik, Vefa Medical, and Faromed.
Turkey's ECG Equipment Market is expected to witness growth from $71 Mn in 2022 to $130 Mn in 2030 with a CAGR of 7.80% for the forecasted year 2022-30. The demand for healthcare services and ECG equipment is rising in Turkey as a result of the country's older population. The market is segmented by product type and by end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Turkey's Coronary Stents Market is expected to witness growth from $90 Mn in 2022 to $136 Mn in 2030 with a CAGR of 5.25% for the forecasted year 2022-30. The demand for coronary stents is anticipated to rise in Turkey as patients and healthcare professionals become more aware of the advantages of coronary stents. Manufacturers who invest in educational programs to spread the word about the advantages of coronary stents may be able to enhance their market share. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Turkey's Contraceptive Devices Market is expected to witness growth from $103 Mn in 2022 to $198 Mn in 2030 with a CAGR of 8.50% for the forecasted year 2022-30. The proportion of women working in Turkey has been rising significantly in recent years. As women balance their jobs with family planning and childrearing, this has led to a larger need for family planning and contraception. The market is segmented by type and by gender. Some key players in this market include Tubitak Marmara, Acibadem Labmed, Megasan Medikal, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Turkey's Cardiac Surgery Instruments Market is expected to witness growth from $17 Mn in 2022 to $29 Mn in 2030 with a CAGR of 7.10% for the forecasted year 2022-30. Turkish healthcare is of a high caliber, and it is less expensive than that of other nations, making it a common destination for medical tourists. This has increased demand for medical equipment, including instruments used in cardiac surgery, and is predicted to propel market expansion. The market is segmented by type, application, and end user. Some key players in this market include Ersamed Medikal, Acibadem Labmed, Megasan Medikal, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Thailand's Neurology Devices Market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022-30 and will reach $xx Bn in 2030. The increasing prevalence of neurological disorders in Thailand has a significant impact on the demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Johnson and Johnson, Siemens, GE Healthcare, Philips Healthcare, and Boston Scientific.
Thailand's ENT Devices Market is projected to grow from $28 Mn in 2022 to $45 Mn by 2030, registering a CAGR of 6.1% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Thailand ENT devices market include KMS Medical, 4C Medical Instrument, and Nitan Medical.
Thailand Coronary Stents Market is expected to witness growth from $14 Mn in 2022 to $20 Mn in 2030 with a CAGR of 5.09% for the forecasted year 2022-30. One of the main factors propelling market expansion in Thailand is the increasing incidence and prevalence of coronary artery disease. Demand for coronary stents and related goods is projected to rise as more patients are given a diagnosis of coronary artery disease. The market is segmented by type, by mode of delivery, by materials and by end user. Some key players in this market include Xovic, Meticuly, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific and Philips Healthcare.
Thailand's Contraceptive Devices Market is expected to witness growth from $15 Mn in 2022 to $29 Mn in 2030 with a CAGR of 8.34% for the forecasted year 2022-30. In Thailand, due to a growing awareness of the benefits of family planning, there is a rising demand for contraceptive methods in the Market. The market is segmented by type and by gender. Some key players in this market include Unison Laboratories, Thai Nippon Rubber Industry, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Tanzania ECG Equipment Market is expected to witness growth from $4 Mn in 2022 to $7 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-30. In recent years, the private sector has increased its participation in Tanzania's healthcare industry, particularly in the form of P3s. As private sector providers look to invest in top-of-the-line equipment to deliver better services to their clients, this is anticipated to present possibilities for manufacturers of ECG equipment. The market is segmented by product type and by end user. Some key players in this market include Zenufa Laboratories, Crown Healthcare, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Tanzania's Contraceptive Devices Market is expected to witness growth from $5 Mn in 2022 to $10 Mn in 2030 with a CAGR of 8.90% for the forecasted year 2022-30. In Tanzania, there is a rising awareness of and need for family planning, spurred by the need to enhance social and economic conditions, mother and child health outcomes, and other aspects. As a result, there is now a higher need for contraceptive methods, which presents growth potential for manufacturers. The market is segmented by type and by gender. Some key players in this market include Zenufa Laboratories, Crown Healthcare, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Spain's ENT Devices Market is projected to grow from $450 Mn in 2022 to $650 Mn by 2030, registering a CAGR of 4.8% during the forecast period of 2022 -30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Spain ENT devices market include Interacoustics, Facoelche, and Schuco.
Spain's Coronary Stents Market is expected to witness growth from $218 Mn in 2022 to $293 Mn in 2030 with a CAGR of 3.75% for the forecasted year 2022-30. In Spain, procedures involving coronary stents are minimally invasive, which may lead to shorter hospital stays, quicker recoveries, and lower healthcare expenses. As a result, Spain is seeing an increase in the use of minimally invasive techniques, which is fueling the need for coronary stents. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Medlumics, Devicare, Ekuore, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Spain's Contraceptive Devices Market is expected to witness growth from $249 Mn in 2022 to $428 Mn in 2030 with a CAGR of 7.00% for the forecasted year 2022-30. Spain's population is expanding, which is fueling a rise in the need for contraceptive methods. This is because more people are engaging in sexual activity and need reliable contraception to avoid unexpected pregnancies. The market is segmented by type and by gender. Some key players in this market include Ferrer, Laboratorios Rubió, Almirall, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.
This report presents a strategic analysis of the South Korea Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korea Medical Devices Market reports, offering unmatched value, accuracy, and expert insights.
South Korean ENT Devices Market is projected to grow from $340 Mn in 2022 to $570 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the South Korean ENT devices market include Otosys, MediVision, and NeomediTech.
South Korean ECG Equipment Market is expected to witness growth from $130 Mn in 2022 to $246 Mn in 2030 with a CAGR of 8.30% for the forecasted year 2022-30. In South Korea, there is an increasing awareness of the value of early diagnosis and prevention of heart disease, which has resulted in the establishment of numerous screening programs and initiatives. Due to this, there is no more need for ECG equipment as a screening tool for heart disease early detection. The market is segmented by product type and by end user. Some key players in this market include Nanoomtech, L&K Biomed, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
South Korea's Coronary Stents Market is expected to witness growth from $165 Mn in 2022 to $258 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-30. In South Korea, the frequency of coronary artery illness is increasing which is anticipated to increase demand for coronary stents. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Nanoomtech, Kolon Life Science, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
South Korea's Contraceptive Devices Market is expected to witness growth from $188 Mn in 2022 to $376 Mn in 2030 with a CAGR of 9.00% for the forecasted year 2022-30. In recent years, South Korea has become more aware of and accepting of family planning and the use of contraceptives. The demand for these devices has increased as a result. The market is segmented by type and by gender. Some key players in this market include Hanmi Pharm, Dong-A ST, Bukwang Pharmaceutical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
This report presents a strategic analysis of the South Africa Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Africa Pain Management Devices Market, offering unmatched value, accuracy, and expert insights.
South Africa ENT Devices Market is projected to grow from $150 Mn in 2022 to $260 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the South Africa ENT devices market include SONIC Innovations, Medtronic South Africa, and ENRAF Nonius.
South Africa's Coronary Stents Market is expected to grow from $73 Mn in 2022 to $117 Mn in 2030 with a CAGR of 5.98% for the forecasted year 2022-30. A greater percentage of the population in South Africa is over 60 years old, signaling an aging population. This group is more likely to have coronary artery disease, which is projected to boost demand for coronary stents. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include SSEM Mthembu Medical, NuAngle Medical, Tekmed, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
South Africa Biomaterials in Healthcare Market is expected to grow from $1.01 Bn in 2022 to $2.98 Bn in 2030 with a CAGR of 14.43% for the forecasted year 2022-30. The lengthy life expectancy and increase in persistent health conditions in South Africa are increasing demand for medical implants, such as dental implants, spinal implants, and joint replacements. This demand is expected to lead to a rise in the demand for the biomaterials used in medical devices. The market is segmented by type and by application. Some key players in this market include Gabler Medical, Sinapi Biomedical, BASF SE, Johnson and Johnson, Medtronic, and Evonik Industries.
Singapore ENT Devices Market is projected to grow from $30 Mn in 2022 to $50 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Singapore ENT devices market include STAR Institute of Microelectronics, Clarion Medical Technologies, and Clariti Medical.